aluates Reports

$ 0.0

Automative

Inactivated Poliovirus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-2Y715

Global Inactivated Poliovirus Vaccine Market Professional Survey Report 2019

BUY CHAPTERS

Inactivated Poliovirus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-2Y715

Report

September 2024

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

GSK

Serum Institute (Bilthoven Biologicals)

IMBCA

Inactivated Poliovirus Vaccine - Market Size

The global market for Inactivated Poliovirus Vaccine was estimated to be worth US$ 688.5 million in 2023 and is forecast to a readjusted size of US$ 926.8 million by 2030 with a CAGR of 4.4% during the forecast period 2024-2030

Inactivated Poliovirus Vaccine - Market

Inactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inactivated Poliovirus Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Inactivated Poliovirus Vaccine by region & country, by Type, and by Application.

The Inactivated Poliovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Poliovirus Vaccine.

Market Segmentation

Scope of Inactivated Poliovirus Vaccine - Market Report

Report Metric	Details
Report Name	Inactivated Poliovirus Vaccine - Market
Forecasted market size in 2030	US$ 926.8 million
CAGR	4.4%
Forecasted years	2024 - 2030
Segment by Type:	Human Diploid Cell Monkey Kidney Cell
Segment by Application	Public Private
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, GSK, Serum Institute (Bilthoven Biologicals), IMBCA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Inactivated Poliovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Inactivated Poliovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Inactivated Poliovirus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Inactivated Poliovirus Vaccine - Market size in 2030?

Ans: The Inactivated Poliovirus Vaccine - Market size in 2030 will be US$ 926.8 million.

Who are the main players in the Inactivated Poliovirus Vaccine - Market report?

Ans: The main players in the Inactivated Poliovirus Vaccine - Market are Sanofi, GSK, Serum Institute (Bilthoven Biologicals), IMBCA

What are the Application segmentation covered in the Inactivated Poliovirus Vaccine - Market report?

Ans: The Applications covered in the Inactivated Poliovirus Vaccine - Market report are Public, Private

What are the Type segmentation covered in the Inactivated Poliovirus Vaccine - Market report?

Ans: The Types covered in the Inactivated Poliovirus Vaccine - Market report are Human Diploid Cell, Monkey Kidney Cell

Recommended Reports

Vaccine Markets

Polio And Flu

Vaccine Supply Chain

1 Market Overview

1.1 Inactivated Poliovirus Vaccine Product Introduction

1.2 Global Inactivated Poliovirus Vaccine Market Size Forecast

1.2.1 Global Inactivated Poliovirus Vaccine Sales Value (2019-2030)

1.2.2 Global Inactivated Poliovirus Vaccine Sales Volume (2019-2030)

1.2.3 Global Inactivated Poliovirus Vaccine Sales Price (2019-2030)

1.3 Inactivated Poliovirus Vaccine Market Trends & Drivers

1.3.1 Inactivated Poliovirus Vaccine Industry Trends

1.3.2 Inactivated Poliovirus Vaccine Market Drivers & Opportunity

1.3.3 Inactivated Poliovirus Vaccine Market Challenges

1.3.4 Inactivated Poliovirus Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Inactivated Poliovirus Vaccine Players Revenue Ranking (2023)

2.2 Global Inactivated Poliovirus Vaccine Revenue by Company (2019-2024)

2.3 Global Inactivated Poliovirus Vaccine Players Sales Volume Ranking (2023)

2.4 Global Inactivated Poliovirus Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Inactivated Poliovirus Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Inactivated Poliovirus Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Inactivated Poliovirus Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Inactivated Poliovirus Vaccine

2.9 Inactivated Poliovirus Vaccine Market Competitive Analysis

2.9.1 Inactivated Poliovirus Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Inactivated Poliovirus Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Poliovirus Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Human Diploid Cell

3.1.2 Monkey Kidney Cell

3.2 Global Inactivated Poliovirus Vaccine Sales Value by Type

3.2.1 Global Inactivated Poliovirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Inactivated Poliovirus Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Inactivated Poliovirus Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Inactivated Poliovirus Vaccine Sales Volume by Type

3.3.1 Global Inactivated Poliovirus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Inactivated Poliovirus Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Inactivated Poliovirus Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Inactivated Poliovirus Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Public

4.1.2 Private

4.2 Global Inactivated Poliovirus Vaccine Sales Value by Application

4.2.1 Global Inactivated Poliovirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Inactivated Poliovirus Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Inactivated Poliovirus Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Inactivated Poliovirus Vaccine Sales Volume by Application

4.3.1 Global Inactivated Poliovirus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Inactivated Poliovirus Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Inactivated Poliovirus Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Inactivated Poliovirus Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Inactivated Poliovirus Vaccine Sales Value by Region

5.1.1 Global Inactivated Poliovirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Inactivated Poliovirus Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Inactivated Poliovirus Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Inactivated Poliovirus Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Inactivated Poliovirus Vaccine Sales Volume by Region

5.2.1 Global Inactivated Poliovirus Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Inactivated Poliovirus Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Inactivated Poliovirus Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Inactivated Poliovirus Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Inactivated Poliovirus Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Inactivated Poliovirus Vaccine Sales Value, 2019-2030

5.4.2 North America Inactivated Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Inactivated Poliovirus Vaccine Sales Value, 2019-2030

5.5.2 Europe Inactivated Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Inactivated Poliovirus Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Inactivated Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Inactivated Poliovirus Vaccine Sales Value, 2019-2030

5.7.2 South America Inactivated Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Inactivated Poliovirus Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Inactivated Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Inactivated Poliovirus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Inactivated Poliovirus Vaccine Sales Value

6.2.1 Key Countries/Regions Inactivated Poliovirus Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Inactivated Poliovirus Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Inactivated Poliovirus Vaccine Sales Value, 2019-2030

6.3.2 United States Inactivated Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Inactivated Poliovirus Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Inactivated Poliovirus Vaccine Sales Value, 2019-2030

6.4.2 Europe Inactivated Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Inactivated Poliovirus Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Inactivated Poliovirus Vaccine Sales Value, 2019-2030

6.5.2 China Inactivated Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Inactivated Poliovirus Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Inactivated Poliovirus Vaccine Sales Value, 2019-2030

6.6.2 Japan Inactivated Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Inactivated Poliovirus Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Inactivated Poliovirus Vaccine Sales Value, 2019-2030

6.7.2 South Korea Inactivated Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Inactivated Poliovirus Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Inactivated Poliovirus Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Inactivated Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Inactivated Poliovirus Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Inactivated Poliovirus Vaccine Sales Value, 2019-2030

6.9.2 India Inactivated Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Inactivated Poliovirus Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Sanofi

7.1.1 Sanofi Company Information

7.1.2 Sanofi Introduction and Business Overview

7.1.3 Sanofi Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Sanofi Inactivated Poliovirus Vaccine Product Offerings

7.1.5 Sanofi Recent Development

7.2 GSK

7.2.1 GSK Company Information

7.2.2 GSK Introduction and Business Overview

7.2.3 GSK Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 GSK Inactivated Poliovirus Vaccine Product Offerings

7.2.5 GSK Recent Development

7.3 Serum Institute (Bilthoven Biologicals)

7.3.1 Serum Institute (Bilthoven Biologicals) Company Information

7.3.2 Serum Institute (Bilthoven Biologicals) Introduction and Business Overview

7.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product Offerings

7.3.5 Serum Institute (Bilthoven Biologicals) Recent Development

7.4 IMBCA

7.4.1 IMBCA Company Information

7.4.2 IMBCA Introduction and Business Overview

7.4.3 IMBCA Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 IMBCA Inactivated Poliovirus Vaccine Product Offerings

7.4.5 IMBCA Recent Development

8 Industry Chain Analysis

8.1 Inactivated Poliovirus Vaccine Industrial Chain

8.2 Inactivated Poliovirus Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Inactivated Poliovirus Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Inactivated Poliovirus Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Sanofi

GSK

Serum Institute (Bilthoven Biologicals)

IMBCA

List of Tables

Table 1. Inactivated Poliovirus Vaccine Market Trends

Table 2. Inactivated Poliovirus Vaccine Market Drivers & Opportunity

Table 3. Inactivated Poliovirus Vaccine Market Challenges

Table 4. Inactivated Poliovirus Vaccine Market Restraints

Table 5. Global Inactivated Poliovirus Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Inactivated Poliovirus Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Inactivated Poliovirus Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Inactivated Poliovirus Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Inactivated Poliovirus Vaccine Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Inactivated Poliovirus Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Inactivated Poliovirus Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Inactivated Poliovirus Vaccine

Table 13. Global Inactivated Poliovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Poliovirus Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Inactivated Poliovirus Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Inactivated Poliovirus Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Inactivated Poliovirus Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Inactivated Poliovirus Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Inactivated Poliovirus Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Inactivated Poliovirus Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Inactivated Poliovirus Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Inactivated Poliovirus Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Inactivated Poliovirus Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Inactivated Poliovirus Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Inactivated Poliovirus Vaccine Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Inactivated Poliovirus Vaccine Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Inactivated Poliovirus Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Inactivated Poliovirus Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Inactivated Poliovirus Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Inactivated Poliovirus Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Inactivated Poliovirus Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Inactivated Poliovirus Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Inactivated Poliovirus Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Inactivated Poliovirus Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Inactivated Poliovirus Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Inactivated Poliovirus Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Inactivated Poliovirus Vaccine Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Inactivated Poliovirus Vaccine Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Inactivated Poliovirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Inactivated Poliovirus Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Inactivated Poliovirus Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Inactivated Poliovirus Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Inactivated Poliovirus Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Inactivated Poliovirus Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Inactivated Poliovirus Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Inactivated Poliovirus Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Inactivated Poliovirus Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Inactivated Poliovirus Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Inactivated Poliovirus Vaccine Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Inactivated Poliovirus Vaccine Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Inactivated Poliovirus Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Inactivated Poliovirus Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Inactivated Poliovirus Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Inactivated Poliovirus Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Inactivated Poliovirus Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. Sanofi Company Information

Table 58. Sanofi Introduction and Business Overview

Table 59. Sanofi Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Sanofi Inactivated Poliovirus Vaccine Product Offerings

Table 61. Sanofi Recent Development

Table 62. GSK Company Information

Table 63. GSK Introduction and Business Overview

Table 64. GSK Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. GSK Inactivated Poliovirus Vaccine Product Offerings

Table 66. GSK Recent Development

Table 67. Serum Institute (Bilthoven Biologicals) Company Information

Table 68. Serum Institute (Bilthoven Biologicals) Introduction and Business Overview

Table 69. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product Offerings

Table 71. Serum Institute (Bilthoven Biologicals) Recent Development

Table 72. IMBCA Company Information

Table 73. IMBCA Introduction and Business Overview

Table 74. IMBCA Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. IMBCA Inactivated Poliovirus Vaccine Product Offerings

Table 76. IMBCA Recent Development

Table 77. Key Raw Materials Lists

Table 78. Raw Materials Key Suppliers Lists

Table 79. Inactivated Poliovirus Vaccine Downstream Customers

Table 80. Inactivated Poliovirus Vaccine Distributors List

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Inactivated Poliovirus Vaccine Product Picture

Figure 2. Global Inactivated Poliovirus Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Inactivated Poliovirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Inactivated Poliovirus Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Inactivated Poliovirus Vaccine Sales Price (2019-2030) & (USD/Unit)

Figure 6. Inactivated Poliovirus Vaccine Report Years Considered

Figure 7. Global Inactivated Poliovirus Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Inactivated Poliovirus Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Inactivated Poliovirus Vaccine Revenue in 2023

Figure 10. Inactivated Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Human Diploid Cell Picture

Figure 12. Monkey Kidney Cell Picture

Figure 13. Global Inactivated Poliovirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Inactivated Poliovirus Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Inactivated Poliovirus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Inactivated Poliovirus Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Inactivated Poliovirus Vaccine Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Public

Figure 19. Product Picture of Private

Figure 20. Global Inactivated Poliovirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Inactivated Poliovirus Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Inactivated Poliovirus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Inactivated Poliovirus Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Inactivated Poliovirus Vaccine Price by Application (2019-2030) & (USD/Unit)

Figure 25. North America Inactivated Poliovirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Inactivated Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Inactivated Poliovirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Inactivated Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Inactivated Poliovirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Inactivated Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Inactivated Poliovirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Inactivated Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Inactivated Poliovirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Inactivated Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Inactivated Poliovirus Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Inactivated Poliovirus Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Inactivated Poliovirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Inactivated Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Inactivated Poliovirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Inactivated Poliovirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Inactivated Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Inactivated Poliovirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Inactivated Poliovirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Inactivated Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Inactivated Poliovirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Inactivated Poliovirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Inactivated Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Inactivated Poliovirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Inactivated Poliovirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Inactivated Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Inactivated Poliovirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Inactivated Poliovirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Inactivated Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Inactivated Poliovirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Inactivated Poliovirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Inactivated Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Inactivated Poliovirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Inactivated Poliovirus Vaccine Industrial Chain

Figure 59. Inactivated Poliovirus Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Inactivated Polio Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inactivated Polio and Rabies Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Polio Vaccination Market Research Report 2025

Global Poliomyelitis Vaccine Market Research Report 2025

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Combined Polio Vaccine Market Research Report 2024

Polio Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Poliomycetes Vaccine Market Insights Forecast to 2030

Global Pet Inactivated Vaccine Market Research Report 2025

Inactivated Vaccine Market

Inactivated Vaccine for Swine Mycoplasma Pneumonia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inactivated Polio Virus Vaccine Market Research Report 2025

Porcine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sabin Inactivated Polio vaccine sIPV Market Research Report 2025

Swine Hyopneumoniae Mycoplasma Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Live Attenuated Polio Vaccine Market Research Report 2024

Global IPV Vaccine Market Research Report 2025

Global Poliomyelitis Vaccine in Dragee Candy Market Research Report 2025

Global Oral Polio Vaccines OPV Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions